These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 19969358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA, Su A, Ra S, Cappel MA, Louissant A, Knudson RA, Ketterling RP, Said J, Binder S, Harris NL, Feldman AL, Kim J, Kim YH, Gratzinger D.
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [Abstract] [Full Text] [Related]

  • 5. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
    Tomaszewski MM, Lupton GP, Krishnan J, May DL.
    J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
    [Abstract] [Full Text] [Related]

  • 6. Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides.
    Mitteldorf C, Robson A, Tronnier M, Pfaltz MC, Kempf W.
    Dermatology; 2015 Aug; 231(2):164-70. PubMed ID: 26111483
    [Abstract] [Full Text] [Related]

  • 7. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.
    Aoki M, Niimi Y, Takezaki S, Azuma A, Seike M, Kawana S.
    Br J Dermatol; 2001 Jul; 145(1):123-6. PubMed ID: 11453920
    [Abstract] [Full Text] [Related]

  • 8. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
    Paulli M, Berti E, Rosso R, Boveri E, Kindl S, Klersy C, Lazzarino M, Borroni G, Menestrina F, Santucci M.
    J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
    [Abstract] [Full Text] [Related]

  • 9. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
    Wada DA, Law ME, Hsi ED, Dicaudo DJ, Ma L, Lim MS, Souza Ad, Comfere NI, Weenig RH, Macon WR, Erickson LA, Ozsan N, Ansell SM, Dogan A, Feldman AL.
    Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
    [Abstract] [Full Text] [Related]

  • 10. Primary cutaneous anaplastic large-cell lymphoma of the eyelid: report of two cases and review of the literature.
    Iuliano A, Fossataro F, Laezza MP, Lanni V, Mascolo M, Varricchio S, Uccello G, Tranfa F, Strianese D.
    Orbit; 2021 Dec; 40(6):481-487. PubMed ID: 32998605
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.
    McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C.
    J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002
    [Abstract] [Full Text] [Related]

  • 13. Disseminated CD8-positive, CD30-positive cutaneous lymphoproliferative eruption with overlapping features of mycosis fungoides and primary cutaneous anaplastic large cell lymphoma following remote solitary lesional presentation.
    Davick JJ, Mutgi KAJ, Wanat KA, Link BK, Liu V.
    J Cutan Pathol; 2017 Aug; 44(8):703-712. PubMed ID: 28497585
    [Abstract] [Full Text] [Related]

  • 14. Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders.
    Liang X, Smoller BR, Golitz LE.
    J Cutan Pathol; 2002 Sep; 29(8):459-64. PubMed ID: 12207739
    [Abstract] [Full Text] [Related]

  • 15. Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas?
    Cieza-Díaz DE, Prieto-Torres L, Rodríguez-Pinilla SM, Córdoba Mascuñano R, Manso Alonso R, Machan S, Piris Pinilla MÁ, Requena Caballero L.
    Am J Dermatopathol; 2019 Nov; 41(11):846-850. PubMed ID: 30946099
    [Abstract] [Full Text] [Related]

  • 16. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Müller B, Pfaltz M.
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [Abstract] [Full Text] [Related]

  • 17. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A, Tinguely M, Pfaltz M, Burghart DR, Kempf W.
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Primary cutaneous CD30(+) lymphoproliferative disorders.
    Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M.
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.